2 active not recruiting. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Active not recruiting 2 |
Follow Pseudohypoparathyroidism: new trials by email Literature Review of Pseudohypoparathyroidism trials Research Report on Pseudohypoparathyroidism
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Theophylline Treatment for Pseudohypoparathyroidism - Children 2-12 Years Old Theophylline, Placebo - Pseudohypoparathyroidism, Albright Hereditary Osteodystrophy | Phase 2 | Active not recruiting | Vanderbilt University Medical Center | 34 | 2020-07-13 | 2026-04-29 |
| Theophylline Treatment for Pseudohypoparathyroidism Theophylline, Placebos - Pseudohypoparathyroidism, Albright Hereditary Osteodystrophy | Phase 2 | Active not recruiting | Vanderbilt University Medical Center | 29 | 2018-09-01 | 2026-09-02 |
Bone Diseases (2) · Bone Diseases, Metabolic (2) · Calcium Metabolism Disorders (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Genetic Diseases, Inborn (2) · Metabolic Diseases (2) · Metabolism, Inborn Errors (2) · Metal Metabolism, Inborn Errors (2) · Musculoskeletal Diseases (2) · Nutritional and Metabolic Diseases (2)
Theophylline (2)
Vanderbilt University Medical Center (2)
United States (2)